Zobrazeno 1 - 10 of 24 pro vyhledávání: '"Paresh, Chaudhari"'
2
Akademický článek
Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
Autor: Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn
Publikováno v: Journal of Health Economics and Outcomes Research, Vol 1, Iss 2 (2013)
**Objectives:** To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. **Methods:** Adults wit
Externí odkaz: https://doaj.org/article/b72248b833a54b9cb1bbf12087f020e5
Zobrazit plný text záznamu
3
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
Autor: Raafat Seifeldin, Ernest H. Law, Ruixuan Jiang, Paresh Chaudhari, Anna P. Fang, Jing Zhao, Hongbo Yang, Eric Q. Wu, Zhou Zhou
Publikováno v: Diabetes Therapy
Introduction Diabetic nephropathy (DN) is a progressive kidney disease resulting as a complication of diabetes mellitus. This study evaluated the disease progression and economic burden of DN among commercially insured patients with type 2 diabetes i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ce92ad98dcdbc61828c537f241788e
http://europepmc.org/articles/PMC5446382
Zobrazit plný text záznamu
4
Evaluation of patients with type 2 diabetes mellitus receiving treatment during the pre-diabetes period: Is early treatment associated with improved outcomes?
Autor: Ernest H. Law, Paresh Chaudhari, Carlos Vallarino, Raafat Seifeldin
Publikováno v: Diabetes Research and Clinical Practice. 122:162-169
This study evaluates the association of pretreatment with oral antidiabetics (OADs) on clinical outcomes and health resource utilization among commercially insured type II diabetes mellitus (T2DM) patients in the United States.Using administrative da
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5feffb8cc56a687d515a88e240534172
https://doi.org/10.1016/j.diabres.2016.10.020
Zobrazit plný text záznamu
5
Validation of a Patient-reported Outcome (PRO) Measure and a Clinician-reported Outcome (CRO) Measure to Assess Satisfaction with Pharmacologic Stress Agents for Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Autor: Paresh Chaudhari, Stacie Hudgens, James Spalding
Publikováno v: Clinical Therapeutics. 38:1141-1150
Purpose The objective of this study was to develop and validate clinician and patient measures of satisfaction for pharmacologic stress agents (PSAs) used in single-photon emission computed tomography myocardial perfusion imaging procedures. Methods
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a954630ecb5505b2bda5a6c2182f86f6
https://doi.org/10.1016/j.clinthera.2016.02.024
Zobrazit plný text záznamu
6
Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
Autor: Paul Juneau, Paresh Chaudhari, David Horn, Robert Fowler, Donna McMorrow, Emily Durden
Publikováno v: Journal of Health Economics and Outcomes Research
**Objectives:** To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. **Methods:** Adults with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f9c39e370c5980967020423c5abaab
https://doi.org/10.36469/9862
Zobrazit plný text záznamu
7
Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups
Autor: Robert J. Taylor, Rebecca S Campbell, Paresh Chaudhari, Brian H. Nathanson, David Horn, Harlen Hays, Samuel A Bozzette
Publikováno v: ClinicoEconomics and Outcomes Research: CEOR
Rebecca S Campbell,1 Paresh Chaudhari,2 Harlen D Hays,1 Robert J Taylor,1 Brian H Nathanson,3 Samuel A Bozzette,1 David Horn4 1Cerner Research, Culver City, CA, USA; 2Astellas Scientific and Medical Affairs, Inc., Northbrook, IL, USA; 3OptiStatim, LL
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0168a45547dcdefa661a11a99ff385d
http://europepmc.org/articles/PMC3810329
Zobrazit plný text záznamu
9
Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting
Autor: Rolin L Wade, David Horn, Harlen Hays, Paresh Chaudhari, Jing Yi, Brian H. Nathanson, Rebecca S Campbell
Publikováno v: Journal of Medical Economics. 15:1130-1138
Real-world data on patients treated with echinocandins for candidemia are limited. This study examined the effect of three echinocandin-based treatment regimens on resource utilization in patients with Candida infection.A retrospective cohort study o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e98da4c339414084b7531b4d839ce6e
https://doi.org/10.3111/13696998.2012.708690
Zobrazit plný text záznamu
10
Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States
Autor: Eric Q. Wu, Zheng-Yi Zhou, Chad Patel, Hongbo Yang, Paresh Chaudhari, David Horn
Publikováno v: Applied health economics and health policy. 12(1)
Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2f77c140c122bd4429036cc66157d8
https://pubmed.ncbi.nlm.nih.gov/24385260
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje